BrainLab has received 510(k) clearance from the FDA for its HybridArc radiosurgery planning software.
HybridArc expands upon the Dynamic Arc stereotactic treatment technique to offer high dose conformity to the target. The software package uses an adaptive dose calculation matrix that takes into account the different parameters affecting dose distribution to provide precision when opting for stereotactic radiosurgery.
According to Munich-based BrainLab, HybridArc can be deployed in hospitals that either have Linac treatment technology or those that want to gain the capability of radiosurgery without a hardware upgrade. Treatments can be delivered on most Linac-based radiosurgery systems.